RecruitingNCT06751797

Balance Confidence and Kinesiophobia in Parkinson's Disease

Balance Confidence, Kinesiophobia, and Associated Factors in Parkinson's Disease: A Controlled Study

Sponsor

Beylikduzu State Hospital

Enrollment

62 participants

Start Date

Dec 10, 2024

Study Type

OBSERVATIONAL

Conditions

Parkinson Disease

Summary

31 patients aged 50-80 years diagnosed with idiopathic Parkinson's disease (Modified Hoehn-Yahr stages 1-3) and 31 healthy volunteers. At the start of the study, sociodemographic data for all participants will be recorded. To assess the mental and functional status of Parkinson's disease patients, the Mini-Mental State Examination (MMSE) and the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) will be used. Balance confidence levels will be assessed using the Activities-specific Balance Confidence Scale-6 (ABC-6), overall balance using the Berg Balance Scale (BBS), fear of falling using the Falls Efficacy Scale (FES), and kinesiophobia levels using the Tampa Scale of Kinesiophobia (TSK).

Eligibility

Min Age: 50 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study explores how balance confidence and fear of movement (kinesiophobia) affect people with Parkinson's disease, and how these psychological factors relate to physical function. **You may be eligible if...** - You have been diagnosed with Parkinson's disease by a neurologist - Your Parkinson's is in stages 1–3 on the Hoehn and Yahr scale (mild to moderate) - You scored 24 or higher on a standard memory and thinking test (MMSE) - You are between 50 and 80 years old - You volunteered to participate **You may NOT be eligible if...** - You take medications (other than standard Parkinson's drugs) that affect balance or muscle strength - You have other neurological or musculoskeletal conditions beyond Parkinson's - You have a psychiatric disorder or significant cognitive impairment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.